Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphopenia / Immunoparalysis in Critically Ill Adults”

2 trials

Showing 2 of 2 results

Large-scale testing (Phase 3)WithdrawnNCT07492875
What this trial is testing

Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia

Who this might be right for
Community-Acquired Pneumonia (CAP)Acute Respiratory Distress Syndrome (ARDS)Sepsis+2 more
ImmunityBio, Inc.
Testing effectiveness (Phase 2)WithdrawnNCT07492888
What this trial is testing

Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS)

Who this might be right for
Acute Respiratory Distress SyndromeSevere Community-Acquired PneumSepsis+1 more
ImmunityBio, Inc.

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation